/CNC
Centene Corporation
CNC • NYSECNC • NYSE • Healthcare
$35.32+1.09%+0.38
$35.32+1.09%(+0.38)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
100Bullish
Risk
100Low Risk
Momentum
27Negative
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
12.2%▲1.9pp
Revenue after COGS
Operating
-3.9%▼5.9pp
After operating expenses
Net
-3.4%▼5.5pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
-3.0
Price vs earnings
EV/EBITDA
-4.1
Enterprise value
FCF Yield
21.4%
Cash generation
Earnings Yield
-33.0%
Inverse of P/E
Capital Efficiency
-18
GoAI Quality ScorePoor
ROEReturn on Equity
-33.4%Weak
ROAReturn on Assets
-8.6%Weak
ROICReturn on Invested Capital
-13.4%Weak
Financial Health
Current RatioHealthy
1.68
Short-term solvency (>1.5)
Net Debt / EBITDANet Cash
-0.17x
Debt repayment capacity (<3x)
Income QualityWeak
-0.76
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $194.78B | $163.07B | $154.00B | $144.55B | $125.98B |
| Gross Profit | $23.83B | $16.83B | $17.32B | $16.66B | $14.20B |
| Gross Margin | 12.2% | 10.3% | 11.2% | 11.5% | 11.3% |
| Operating Income | -$7.62B | $3.17B | $2.93B | $1.32B | $1.78B |
| Net Income | -$6.67B | $3.31B | $2.70B | $1.20B | $1.35B |
| Net Margin | -3.4% | 2.0% | 1.8% | 0.8% | 1.1% |
| EPS | -$13.61 | $6.33 | $4.97 | $2.09 | $2.31 |
Average Price Target
$44.90▲ 27.1% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for Centene Corporation, the average price target is $44.90, with a high forecast of $59.00 and a low forecast of $38.00. The average price target represents a 27.1% increase from the current price of $35.32.
Highest
$59.00
Average
$44.90
Lowest
$38.00
Rating Distribution
Strong Buy
0
0%
Buy
24
56%
Hold
17
40%
Sell
2
5%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Mizuho● Maintain
Neutral
2026-03-11Morgan Stanley● Maintain
Equal Weight
2026-03-04Wells Fargo● Maintain
Equal Weight
2026-02-18Cantor Fitzgerald● Maintain
Neutral
2026-02-09Wells Fargo● Maintain
Equal Weight
2026-01-07Barclays▲ Upgrade
Equal Weight→Overweight
2026-01-05Bernstein● Maintain
Outperform
2025-11-21Wells Fargo● Maintain
Equal Weight
2025-11-12Barclays● Maintain
Equal Weight
2025-11-04JP Morgan● Maintain
Neutral
2025-11-04Earnings History & Surprises
BEAT RATE
89%
Last 18 quarters
AVG SURPRISE
+22.3%
EPS vs Estimate
BEATS / MISSES
16/2
Last 18 quarters
LATEST EPS
$-1.19
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
+2.5%
$-1.19 vs $-1.22
Q4 '25
+445.4%
$0.50 vs $-0.14
Q3 '25
-243.4%
$-0.16 vs $0.11
Q2 '25
+15.1%
$2.90 vs $2.52
Q1 '25
+81.8%
$0.80 vs $0.44
Q4 '24
+21.8%
$1.62 vs $1.33
Q3 '24
+16.9%
$2.42 vs $2.07
Q2 '24
+8.7%
$2.26 vs $2.08
Q1 '24
+4.7%
$0.45 vs $0.43
Q4 '23
+26.6%
$2.00 vs $1.58
Q3 '23
+3.4%
$2.10 vs $2.03
Q2 '23
+1.0%
$2.11 vs $2.09
No investor questions available.
Latest News
No news available